Edward M Fitzgerald - Net Worth and Insider Trading
Edward M Fitzgerald Net Worth
The estimated net worth of Edward M Fitzgerald is at least $8 Million dollars as of 2025-05-07. Edward M Fitzgerald is the Executive VP of ARIAD Pharmaceuticals Inc and owns about 320,367 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $8 Million. Details can be seen in Edward M Fitzgerald's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Edward M Fitzgerald has not made any transactions after 2016-03-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Edward M Fitzgerald
Edward M Fitzgerald Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Edward M Fitzgerald owns 2 companies in total, including Akcea Therapeutics Inc (AKCA) , and ARIAD Pharmaceuticals Inc (ARIA) .
Click here to see the complete history of Edward M Fitzgerald’s form 4 insider trades.
Insider Ownership Summary of Edward M Fitzgerald
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AKCA | Akcea Therapeutics Inc | 2019-06-14 | director |
| ARIA | ARIAD Pharmaceuticals Inc | 2016-03-21 | Executive VP |
Edward M Fitzgerald Latest Holdings Summary
Edward M Fitzgerald currently owns a total of 1 stock. Edward M Fitzgerald owns 320,367 shares of ARIAD Pharmaceuticals Inc (ARIA) as of March 21, 2016, with a value of $8 Million.
Latest Holdings of Edward M Fitzgerald
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2016-03-21 | 320,367 | 23.99 | 7,685,604 |
Holding Weightings of Edward M Fitzgerald
Edward M Fitzgerald Form 4 Trading Tracker
According to the SEC Form 4 filings, Edward M Fitzgerald has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 5,417 shares on March 21, 2016, which brought Edward M Fitzgerald around $35,048.
Insider Trading History of Edward M Fitzgerald
- 1
Edward M Fitzgerald Trading Performance
Edward M Fitzgerald Ownership Network
Ownership Network List of Edward M Fitzgerald
Ownership Network Relation of Edward M Fitzgerald
Edward M Fitzgerald Owned Company Details
What does Akcea Therapeutics Inc do?
Who are the key executives at Akcea Therapeutics Inc?
Edward M Fitzgerald is the director of Akcea Therapeutics Inc. Other key executives at Akcea Therapeutics Inc include director & Chief Executive Officer Damien Mcdevitt , Chief Medical Officer William T. Andrews , and Chief Financial Officer Michael Dennis Price .
Akcea Therapeutics Inc (AKCA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akcea Therapeutics Inc (AKCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akcea Therapeutics Inc (AKCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akcea Therapeutics Inc (AKCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akcea Therapeutics Inc Insider Transactions
Edward M Fitzgerald Mailing Address
Above is the net worth, insider trading, and ownership report for Edward M Fitzgerald. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Edward M Fitzgerald's mailing address is: C/o Ariad Pharmaceuticals Inc 26 Landsdowne Street Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
